sST2 as a Novel Biomarker for the Prediction of In-hospital Mortality after Coronary Artery Bypass Grafting

OBJECTIVES: Soluble suppression of tumorgenicity 2 (sST2) biomarker is an emerging predictor of adverse clinical outcomes, but its prognostic value for in-hospital mortality after coronary artery bypass grafting (CABG) is not well understood. This study measured the association between operative sST...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomarkers
Autori principali: Stabler, Meagan E., Rezaee, Michael E., Parker, Devin M., MacKenzie, Todd A., Bohm, Andrew R., DiScipio, Anthony W., Malenka, David J., Brown, Jeremiah R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534420/
https://ncbi.nlm.nih.gov/pubmed/30512977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2018.1556338
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi